On June 30, 2026, a trial update was recorded for the study titled "VIrtual STudy in Achondroplasia for the US (VISTA)," registered under NCT06168201, involving vosoritide, an approved compound. The study's current status is listed as recruiting as of this date. No phase information was provided for this trial in the available record.
The trial registry identifies this update through ClinicalTrials.gov under the identifier NCT06168201. As stated in the record, the study remains open for recruitment. No additional details regarding trial design, enrollment numbers, or outcome measures were included in this update.
No results have been posted for this trial in the data provided. This brief reports only the recruitment status and the associated date as recorded in the trial registry entry. Readers seeking further detail on trial design or specific endpoints should consult the official registry listing directly for the most current and complete information.
For more background on vosoritide, including its approved regulatory status, readers can consult the compound overview.